Deerfield logo

Deerfield

North America, New York, United States, New York

Description

Deerfield is an investment firm that transforms healthcare through information, investment, and philanthropy.

Investor Profile

Deerfield has made 175 investments, with 3 in the past 12 months and 35% as lead.

Stage Focus

  • Series C (23%)
  • Series B (20%)
  • Post Ipo Equity (14%)
  • Series A (11%)
  • Series D (11%)
  • Series Unknown (8%)
  • Series E (3%)
  • Post Ipo Debt (3%)
  • Series F (2%)
  • Undisclosed (1%)

Country Focus

  • United States (90%)
  • Israel (2%)
  • Hong Kong (2%)
  • France (2%)
  • Canada (1%)
  • Italy (1%)
  • United Kingdom (1%)
  • Ireland (1%)
  • Bermuda (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Medical Device
  • Genetics
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Deerfield frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 21
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 14
CA
North America, Massachusetts, United States, Boston
Co-Investments: 16
Casdin Capital
North America, New York, United States, New York
Co-Investments: 13
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 13
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 29
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 16
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 14
Venrock
North America, California, United States, Palo Alto
Co-Investments: 12
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 18

Which angels does Deerfield often collaborate with?

JW
North America, California, United States, Mountain View
Shared Deals: 1
AZ
Europe, England, United Kingdom, London
Shared Deals: 2
CW
North America, California, United States, Los Angeles
Shared Deals: 1
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
SP
North America, Illinois, United States, Chicago
Shared Deals: 1
WD
North America, California, United States, Santa Clara
Shared Deals: 1
Daphne Teo
Asia, Singapore
Shared Deals: 1
RS
North America, California, United States, Los Angeles
Shared Deals: 1
JA
North America, California, United States, Los Angeles
Shared Deals: 1
JL
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Deerfield?

The Oncology Institute of Hope and Innovation

Downey, California, United States

The Oncology Institute of Hope and Innovation is providing professional support for those affected by cancer and hematological malignancy.

Health CareHealth DiagnosticsHome Health CareMedicalOncologyPsychology
Post Ipo EquityMar 24, 2025
Amount Raised: $16,500,000
Day One Biopharmaceuticals

South San Francisco, California, United States

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo EquityJul 30, 2024
Amount Raised: $175,000,000
Advanced Medicine Partners

Lake Forest, Illinois, United States

Advanced Medicine Partners is a biotechnology company that specializes in viral vector manufacturing for genes and cells.

BiotechnologyClinical TrialsMedical
Series AJun 5, 2024
Amount Raised: $32,000,000
MMI

Pisa, Toscana, Italy

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Health CareMedicalMedical DeviceRobotics
Series CFeb 21, 2024
Amount Raised: $110,000,000
Cogent Biosciences

Waltham, Massachusetts, United States

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityFeb 13, 2024
Amount Raised: $225,000,000
Valneva

Saint-herblain, Pays de la Loire, France

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo DebtAug 17, 2023
Amount Raised: $50,000,000
Octave

Menlo Park, California, United States

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedicalPrecision Medicine
Series BJul 26, 2023
Amount Raised: $32,500,070
Presidio Medical

South San Francisco, California, United States

Presidio Medical is a medtech company that develops a transformational neuromodulation platform.

Developer PlatformInformation TechnologyMedicalSoftware
Series CJun 26, 2023
Amount Raised: $72,000,000
Bitterroot Bio

Palo Alto, California, United States

Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.

BiotechnologyEmergency MedicineMedical
Series AJun 7, 2023
Amount Raised: $145,000,000
Ray Therapeutics

San Diego, California, United States

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

BiotechnologyHealth CareTherapeutics
Series AMay 16, 2023
Amount Raised: $100,000,000